Glycemic Metrics and Patterns in People With and Without Prediabetes
Abbott Diabetes Care · NCT06921902
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 1
- Study start
- February 28, 2025
- Record last updated
- April 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The FreeStyle Libre 3 Continuous Glucose Monitoring (FSL3) System is used to characterize the glycemic profiles of people with and without a prediabetes diagnosis.
Being studied: FreeStyle Libre 3
Conditions: Pre Diabetes
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Subject must be at least 18 years of age.
- Subject must be willing and able to provide written signed and dated informed consent.
Exclusion Criteria
- Subject has a diagnosis of type 1 diabetes, type 2 diabetes, or gestational diabetes.
- Subject is known to be currently practicing a low-carbohydrate or ketogenic diet at the time of enrollment.
- Subject is known to be pregnant at the time of enrollment.
- Subject has known allergy to medical grade adhesive, isopropyl alcohol and/or ethyl alcohol used to disinfect skin.
- Subject is currently on any form of treatment indicated for the treatment of diabetes.
- Subject is currently on any form of medication indicated for weight loss.
Recruiting US locations
Diabetes and Obesity Care
Bend, OR 97702
Site contact: Eden Miller, D.O.
Study contacts (from the official record)
- MOHAMED NADA, PhD · 5107495416 · adc.clinical@abbott.com
Similar studies in Oregon
All diabetes studies in Oregon →- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Portland, OR + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Boehringer Ingelheim
- Location
- Eugene, OR + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
AbbVie
- Location
- Portland, OR + 36 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Medford, OR + 57 other US sites
- Eligibility basics
- Ages 18–80